MyAverix Finance
F · Healthcare
CESSATECH A/S DK -20 (8GN)
Biotechnology
CESSATECH A/S DK -20 (8GN) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 8GN
CESSATECH A/S DK -20 (8GN) — FAQ
What is 8GN's P/E ratio?
The price-to-earnings (P/E) ratio for CESSATECH A/S DK -20 (8GN) is 25.00 (data as of 2026-05-23).
Does CESSATECH A/S DK -20 pay a dividend?
Dividend yield is not available in the current snapshot for CESSATECH A/S DK -20 (8GN). Check the MyAverix Finance app for the latest dividend data.
What sector is CESSATECH A/S DK -20 in?
CESSATECH A/S DK -20 (8GN) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 8GN listed on?
8GN is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.